1. Home
  2. CXAIW vs IDYA Comparison

CXAIW vs IDYA Comparison

Compare CXAIW & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CXApp Inc. Warrant

CXAIW

CXApp Inc. Warrant

HOLD

Current Price

$0.04

Market Cap

0.0

Sector

Technology

ML Signal

HOLD

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

HOLD

Current Price

$33.70

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CXAIW
IDYA
Founded
N/A
2015
Country
United States
United States
Employees
41
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
2.9B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
CXAIW
IDYA
Price
$0.04
$33.70
Analyst Decision
Strong Buy
Analyst Count
0
13
Target Price
N/A
$49.18
AVG Volume (30 Days)
20.9K
904.3K
Earning Date
03-21-2025
02-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$7,200,000.00
$214,834,000.00
Revenue This Year
N/A
$2,662.86
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
5377.66
52 Week Low
$0.11
$13.45
52 Week High
$0.14
$37.08

Technical Indicators

Market Signals
Indicator
CXAIW
IDYA
Relative Strength Index (RSI) 40.01 47.74
Support Level $0.03 $34.04
Resistance Level $0.05 $35.28
Average True Range (ATR) 0.02 1.07
MACD -0.00 -0.16
Stochastic Oscillator 32.37 22.76

Price Performance

Historical Comparison
CXAIW
IDYA

About CXAIW CXApp Inc. Warrant

CXApp Inc is a provider of AI-powered employee experience solutions, delivering enterprise-grade software that enhances workplace engagement, productivity, and operational efficiency. The company's flagship product, the CXAI Platform, provides a comprehensive suite of tools designed to empower employees and enable organizations to create smarter workplaces. The product's key components include CXAI Apps, CXAI BTS, and CXAI-VU. The company generates the majority of its revenue from Licenses.

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

Share on Social Networks: